巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    SWK Holdings Corp

    SWKH
    18.400
    0.420
    2.23%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・SWK Holdings Corp - 延遲價格・最後更新於 24/06 12:15
    最高位
    19.180
    最低位
    17.910
    開市價
    --
    前收市價
    18.820
    成交量(千)
    3.97
    成交額(百萬)
    0.65
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    236.16
    市盈率
    9.060
    息率
    --
    差價
    --
    52週高低
    20.495 - 16.550
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    SWK Holdings Corp
    證券代碼
    SWKH.US
    所屬板塊
    Asset Management
    公司業務
    SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.
    發行量
    12798494
    公司總部
    14755 Preston Road, Suite 105
    公司網址
    https://www.swkhold.com
    公司電郵
    InvestorRelations@swkhold.com
    公司電話
    +1 972 687-7250
    暫無內容

    關於

    SWK Holdings Corp(SWKH.US)所屬的行業板塊為Asset Management。
    SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.
    詳細公司背景可參考: https://www.swkhold.com